<DOC>
	<DOCNO>NCT01640730</DOCNO>
	<brief_summary>This study patient advance non small cell lung cancer progress despite standard care . The purpose study see Kanglaite injection effect survival .</brief_summary>
	<brief_title>Safety Exploratory Efficacy Kanglaite Injection Non Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<criteria>confirm ( within last 3 month ) progressive Stage IV NSCLC estimate life span 3 month phase angle least 5 measured bioimpedance currently take lipid lower medication imminently life threaten condition preexist liver disease know allergy soybean uncontrolled diabetes uncontrolled disturbance lipid metabolism pregnant lactate pacemaker implantable electronic medical device</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>